FDA accelerated approval of tividenofusp alfa-eknm offers a new treatment for neurologic manifestations in patients with Hunter syndrome.

The FDA has labeled the recall as Class II, meaning the product “may cause temporary or medically reversible adverse health consequences.” The issue claims to be related to slow-roasted tomatoes used ...

In subgroup analyses, no associations seen for oral contraceptive pills, intrauterine devices, medroxyprogesterone acetate injections.

HealthDay News — Glucagon-like peptide-1 (GLP-1) receptor agonists, especially semaglutide, are associated with a reduced risk for worsening of anxiety and depression that co-occur with diabetes and ...

Federal health officials say they are looking into 13 states that require certain health insurance plans to cover abortion. The US Department of Health and Human Services (HHS) has announced that its ...

The oral molecular glue degrader aims to overcome resistance to standard ALK tyrosine kinase inhibitor therapies.

FDA approval of Lifyorli plus nab-paclitaxel offers a new option for platinum-resistant epithelial ovarian cancer after 1 to 3 prior systemic regimens.

Adstiladrin may now be thawed in a water bath following an FDA label update, facilitating more efficient treatment delivery for bladder cancer.

HealthDay News — For patients with breast cancer, administration of pegfilgrastim 72 hours postchemotherapy reduces pegfilgrastim-induced bone pain (PIBP) compared with administration at 24 and 48 ...

Amneal Pharmaceuticals is recalling Magnesium Sulfate in Water for Injection, USP, 4g/100mL, IV bag, Lot AH250162.

Increased fluid intake; diet with normal to high calcium, low protein, low sodium; thiazides may reduce stone recurrence.

HealthDay News — Cardinal Health is recalling some of its alcohol prep pads after tests found possible bacterial contamination that could lead to infections. The company said certain lots of its ...